Introduction
The hepatitis B virus (HBV) genome is present in the nucleus of the infected hepatocyte as a 3n2 kbp covalently closed circular DNA molecule (Ruiz-Opazo et al., 1982) . This DNA is transcribed by the host RNA polymerase, synthesizing RNAs of 3n5, 2n4, 2n1 and 0n7 kb (Yen, 1993) . In transgenic mice containing the complete HBV genome integrated into chromosomal DNA, the HBV transcripts are essentially restricted to the liver and kidney (Araki et al., 1989 ; Farza et al., 1988 ; Guidotti et al., 1995) . Consistent with these observations, it is apparent that liver-enriched transcription factor shave an important role in restricting HBV transcription to the livers of HBV transgenic mice. The enhancer II\nucleo-capsid promoter, which controls the transcription of the 3n5 kb transcript, contains regulatory sequence elements binding the liver-enriched transcription factors C\EBP (Lo! pez-Cabrera et al., 1991 ; Yuh & Ting, 1991) , RXRα (Raney et al., 1997) , PPARα (Raney et al., 1997) , HNF3 (Johnson et al., 1995) and HNF4 (Guo et al., 1993 ; Raney et al., 1997) . The large surface antigen promoter, directing the expression of the 2n4 kb transcript, contains regulatory sequence elements which bind the liver-enriched transcription factors HNF1 (Zhou & Yen, 1991 ; and HNF3 . The enhancer I\X-gene promoter region binds the liver-enriched transcription factors C\EBP (Dikstein et al., 1990 ; Pei & Shih, 1990) , RXRα (Garcia et al., 1993 ; Huan et al., 1995) , PPARα (Huan et al., 1995) , HNF3 (Ori & Shaul, 1995 ; Kosovsky et al., 1996) and HNF4 (Garcia et al., 1993) and probably regulates the level of expression of the 0n7 kb transcript.
Whereas a role for liver-enriched transcription factors in the regulation of transcription of the 3n5, 2n4 and 0n7 kb transcripts has been indicated from transient transfection analysis in cell culture, similar analysis of the major surface antigen promoter, which governs the level of expression of the 2n1 kb HBV RNA, has failed to account for the liver-specific expression of this RNA in the HBV transgenic mouse model system. Transient transfection analysis of the major surface antigen promoter has indicated that the regulatory sequence elements governing transcription of the 2n1 kb transcript are located between k189 and the start site for transcription (Shaul et al., 1986 ; Raney et al., 1989 . Several transcription factors have been identified which bind within this region and regulate the level of transcription from the major surface antigen promoter. All of the identified transcription factors are ubiquitously expressed and include NF1 (Shaul et al., 1986) , Sp1 (Raney et al., 1992) and NF-Y (Lu & Yen, 1996) . Therefore it is unclear why the 2n1 kb transcript is not expressed in many different tissues of HBV transgenic mice. In an attempt to address this issue, the major surface antigen promoter region was examined for sequence elements which had not previously been identified in functional analysis in cell culture but nevertheless were able to interact physically with liver-enriched transcription factors.
HNF3 is a member of the hepatocyte nuclear factor 3\fork head homologue (HFH) family of transcription factors (Lai et al., 1993) . The three members of the HNF3 family, HNF3α, HNF3β and HNF3γ, are preferentially expressed in the liver (Lai et al., , 1991 whereas other members of the HFH family of transcription factors including HNF3α, MFH-1, FKH-6 and HFH-3 are expressed in the kidney Overdier et al., 1997 ; Kaestner et al., 1996 ; Miura et al., 1993) . The HFH polypeptides all contain a region of homology which encodes the DNA binding domain of the transcription factors. This domain forms a structure which is referred to as the ' winged-helix ' motif and is very similar to the structure of histone H5 (Clark et al., 1993) . In this study, a functional HNF3 binding site is reported which is located upstream of the regulatory region of the major surface antigen promoter identified in previous transient transfection analysis. This observation suggests that the liver-specific expression of the 2n1 kb viral RNA observed in vivo may be due to regulation of the major surface antigen promoter by the liver-enriched HNF3 transcription factor. In addition, the nature of this regulation is not apparent in transient transfection analysis suggesting the possibility that HNF3 might be acting, in this case, not as a direct transcriptional transactivator, but as a chromatin remodelling molecule permitting access of ubiquitous transcription factors to the more proximal regulatory elements of the promoter. The observation that a functional HNF3 binding site, previously undetected in transient transfection analysis of HBV promoters, was identified upstream of the HBV polymerase open reading frame also supports the suggestion that HNF3 may regulate viral RNA synthesis by mechanisms other than direct activation of transcription.
Methods
Plasmid constructions. The steps in the cloning of the plasmid constructs used in the transfection experiments were performed by standard techniques (Sambrook et al., 1989) . The plasmids pHBVTATA-LUC, SpHNF3(5)TATALUC, SpHNF3(7)TATALUC, PS1pHNF3(2)TA-TALUC, PS1pHNF3(3)TATALUC, CpE(3)TATALUC, PpHNF3(3)TAT-ALUC, CpB(3)TATALUC and PS1pHNF1(1)TATALUC were constructed by inserting synthetic double-stranded oligonucleotides into sites in the polylinker of p19DLUC. pHBVTATALUC was constructed by inserting a double-stranded oligonucleotide containing the large surface antigen promoter TATA-box element, produced by annealing the oligonucleotides CTATATTATATAAGAGAGAAGCT and TCTCTC-TTATATAATATAGGTAC (spanning HBV coordinates 2773 to 2791), into the SacI and KpnI sites of p19DLUC in the same orientation as the TATA-box element occurs in the HBV genome (Raney et al., 1994) . SpHNF3(5)TATALUC, SpHNF3(7)TATALUC, PS1pHNF3(2)TATAL-UC, PS1pHNF3(3)TATALUC, CpE(3)TATALUC, PpHNF3(3)TATAL-UC, CpB(3)TATALUC and PS1pHNF1(1)TATALUC were made by inserting one to seven copies (as indicated in the construct's designation) of the HBV SpHNF3, PS1pHNF3, CpE, PpHNF3, CpB and PS1pHNF1 double-stranded oligonucleotides into the unique SalI site or HindIII site of pHBVTATALUC. The oligonucleotide pairs used to generate the SpHNF3, PS1pHNF3, CpE, PpHNF3, CpB and PS1pHNF1 doublestranded oligonucleotides were TCGATTCAGAGCAAACACCG and TCGACGGTGTTTGCTCTGAA (oligo SpHNF3, HBV coordinates 2916 to 2931) ( Fig. 1 A) , TCGACACTATTTACACACTCTATG and TCGACATAGAGTGTGTAAATAGTG (oligo PS1pHNF3, HBV coordinates 2742 to 2763), TCGAAGACTGTTTGTTTAAA and TCGA-TTTAAACAAACAGTCT (oligo CpE, HBV coordinates 1713 to 1729), TCGAAGTTATGTCAACACTA and TCGATAGTGTTGACATAA-CT (oligo PpHNF3, HBV coordinates 2161 to 2176) ( Fig. 1 B) , TCGACTGGGAGGAGTT and TCGAAACTCCTCCCAG (oligo CpB, HBV coordinates 1730 to 1743), and AGCTAGTTAATCATTACTTC and AGCTGAAGTAATGATTAACT (oligo PS1pHNF1, HBV coordinates 2719 to 2734). The SpHNF3, PS1pHNF3, CpE, PpHNF3, CpB and PS1pHNF1 double-stranded oligonucleotides span the major surface antigen promoter HNF3 binding site ( Fig. 1 A) , the large surface antigen promoter HNF3 binding site , the nucleocapsid promoter HNF3 binding site 2 (Johnson et al., 1995) , an HNF3 binding site upstream of the polymerase open reading frame ( Fig. 1 B) , the nucleocapsid promoter Sp1 site 2 (Zhang et al., 1993) , and the large surface antigen promoter HNF1 binding site , respectively. The sequence of each construct was verified by dideoxynucleotide sequencing (Sanger et al., 1977) .
The pCMVHNF3β vector expresses the HNF3β polypeptide from the HNF3β cDNA using the cytomegalovirus (CMV) immediate-early promoter (Pani et al., 1992) . The pCMV vector, which lacks a cDNA insert, was generated by digestion of pCMVHNF3β with EcoRI and subsequent ligation. The pGEXHNF3α and pGEXHNF4 vectors express glutathione S-transferase (GST) fusion proteins in E. coli DH5α which include the complete HNF3α and HNF4 polypeptide sequence (Raney et al., , 1997 . Expression and subsequent affinity purification of the GST-HNF3α and GST-HNF4 fusion proteins using glutathione-agarose were performed as described by Smith & Johnson (1988) .
Cells and transfections. The human hepatoma cell lines Huh7 (Nakabayashi et al., 1982) and HepG2.1 (Raney et al., 1990) were grown in RPMI 1640 medium and 10 % foetal bovine serum at 37 mC in 5% CO # \air. Transfections were performed as previously described (Graham & Van der Eb, 1973 ; Sorge et al., 1984) except that six-well plates, containing approximately 3i10& cells per well, were used. The transfected DNA mixture comprised 5 µg of a LUC plasmid and 0n25 µg of pCMVβ, which served as an internal control for transfection efficiency. pCMVβ directs the expression of the E. coli β-galactosidase (β-gal) gene using the CMV immediate-early promoter (Clontech). The DNA mixture also included 0n5 µg of the HNF3β expression vector, pCMVHNF3β, or the control expression vector, pCMV, as indicated. Cell extracts were prepared 40 to 48 h after transfection. Cells were lysed in 150 µl of lysis buffer (0n1 M potassium phosphate, pH 7n8, 0n2%, v\v, Triton X-100) and the cell debris was pelleted by centrifugation for 2 min at 13 000 r.p.m. in a microcentrifuge. The supernatant was assayed for luciferase activity essentially as previously described (De Wet et al., 1987) and for β-galactosidase activity using a Galacto-Light kit (Tropix, Inc.) according to the manufacturer's instructions.
Whole-cell extracts, gel retardation analysis and DNase I footprinting. Nuclear extracts were prepared from Huh7 as described previously (Dignam et al., 1983 ; Raney et al., 1989 ; Sladek et al., 1990) . Gel retardation analysis was performed essentially as described pre- (Galibert et al., 1979) . The nucleotide coordinates are derived from the GenBank database and their position relative to a predominant transcription initiation site for the major surface antigen transcript (j1 ; nucleotide coordinate 3159) is shown in parentheses (Raney et al., 1989) . The underlined sequences represent the HNF3 recognition sequence, the NF1 recognition sequence (Shaul et al., 1986) , the Sp1 recognition sequences (Raney et al., 1992) , and the NF-Y recognition sequence (Lu & Yen, 1996) . The sequences of the HBV double-stranded oligonucleotides SpHNF3, SpA, SpB and PpHNF3 are indicated. The brackets under the sequences span the region protected from DNase I digestion by purified recombinant GST-HNF3α . The HBV major surface antigen promoter HNF3 recognition sequence and the HNF3 recognition sequence upstream of the polymerase open reading frame are shown, and the nucleotides homologous to the HNF3 consensus sequence (Roux et al., 1995 ; Kaufmann et al., 1995) viously . $#P-Labelled double-stranded oligonucleotide (1 ng) (see ' Plasmid constructions ') was incubated with GST fusion polypeptides or 9 µg nuclear extract prior to 4 % polyacrylamide gel electrophoresis and autoradiography. When gel retardation competition analysis was performed, the cell extract was preincubated with 750 ng of cold double-stranded competitor oligonucleotide for 15 min prior to the addition of the $#P-labelled double-stranded oligonucleotide. The oligonucleotide pairs used to generate the CpFL, SpA and SpB doublestranded oligonucleotides used in the gel shift analysis were TCGA-GATTAGGTTAAAGGTCTTTGTACTAG and TCGACTAGTACAA-AGACCTTTAACCTAATC (oligo CpFL, HBV coordinates 1751 to 1778), TCGATGGCCAGACGCCAACA and TCGATGTTGGCGTC-TGGCCA (oligo SpA, HBV coordinates 2970 to 2985), and TCGA-CCTTTTGGGGTGGAGCCCTC and TCGAGAGGGCTCCACCCCA-DADB A. K. Raney and A. McLachlan A. K. Raney and A. McLachlan AAAGG (oligo SpB, HBV coordinates 3035 to 3054). The CpFL, SpA and SpB double-stranded oligonucleotides span the nucleocapsid promoter HNF4 binding site 2 (Raney et al., 1997) , the major surface antigen promoter NF1 binding site (Raney et al., 1992) and the major surface antigen promoter Sp1 binding site 1 (Raney et al., 1992) , respectively.
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The DNase I footprinting assay was performed as described previously (Raney et al., 1989 (Raney et al., , 1992 Briggs et al., 1986) . The reactions contained 1 to 5 ng of end-labelled DNA fragment in a 100 µl reaction mixture containing 10 mM Tris-HCl (pH 7n9), 50 mM KCl, 0n5 mM EDTA, 1 mM DTT, 0n5 mM PMSF, 10 % (v\v) glycerol, and purified recombinant GST-HNF3α polypeptide. Binding was carried out for 15 min at 0 mC and then for 2 min at room temperature, after which 100 µl 5 mM CaCl # , 10 mM MgCl # , containing DNase I, was added at room temperature. The reaction mixture was incubated for 2 min, after which the reaction was stopped by the addition of 200 µl 1% (w\v) SDS, 20 mM EDTA, 200 mM NaCl, containing 125 µg of tRNA\ml. The mixture was precipitated with ethanol and analysed by 6 % ureaacrylamide sequencing gel electrophoresis and autoradiography.
Results
Previous transient transfection studies had functionally located the major surface antigen promoter between k189 and the transcriptional start sites (Shaul et al., 1986 ; Raney et al., 1989 . The regulatory sequence elements within this region interact with ubiquitous transcription factors including NF1, Sp1 and NF-Y (Shaul et al., 1986 ; Raney et al., 1992 ; Lu & Yen, 1996) . In addition, the liver-enriched transcription factors HNF1, HNF3, HNF4, RXRα and PPARα have been shown to have little effect on modulating the level of transcription from the major surface antigen promoter in transient transfection analysis (Raney et al., , 1997 . The reason the HBV 2n1 kb RNA transcribed from the major surface antigen promoter is primarily restricted to the liver of HBV transgenic mice was not apparent from studies performed in cultured cell lines. Based on these observations, it was speculated that a liver-enriched transcription factor might regulate expression from the major surface antigen promoter by mechanism(s) which were not identified using transient transfection analysis. Consequently, the major surface antigen promoter region was examined for sequence elements which might interact with liver-enriched transcription factors. The region of the major surface antigen promoter from k231 to k240 was identified as having 100 % identity to the HNF3 consensus sequence (Fig. 1 A) and was examined further for its ability to interact with the HNF3 transcription factor. In addition, a sequence element upstream from the HBV polymerase open reading frame was identified and characterized which displayed 90 % identity to the HNF3 consensus sequence (Fig. 1 B) .
Identification of HNF3 binding sites in the major surface antigen promoter and upstream from the HBV polymerase open reading frame.
The observation that the major surface antigen promoter region contained a sequence element with homology to the HNF3 consensus sequence prompted DNase I footprinting analysis of this promoter with a purified recombinant GST-HNF3 polypeptide (Fig. 2) . A single HNF3 footprint was observed spanning the promoter region from k224 to k242 and a DNase I hypersensitive site, typical of HNF3 footprints, was observed in the centre of the footprint region (Liu et al., 1991 ; McPherson et al., 1993) . The HNF3 footprint precisely overlapped the region of homology with the HNF3 consensus sequence which is located between k231 and k240 (Fig. 1 A) .
The HNF3 consensus sequence displayed homology to a sequence element located upstream from the HBV polymerase open reading frame (Fig. 1 B) in addition to the sequence element present in the major surface antigen promoter region. DNase I footprinting analysis of this region of the HBV genome with a purified recombinant GST-HNF3α polypeptide was performed and a single HNF3 footprint was observed spanning nucleotide coordinates 2158 to 2178 (Fig. 2) . A DNase I hypersensitive site was located in the centre of the footprint region. The HNF3 footprint precisely mapped to the region of homology with the HNF3 consensus sequence, which is located between nucleotide coordinates 2164 and 2173 (Fig. 1 B) .
To characterize further the specificity of the binding of the purified recombinant GST-HNF3α polypeptide to the binding sites in the major surface antigen promoter and upstream of the polymerase open reading frame, gel shift analysis was performed using the double-stranded oligonucleotides PpHNF3 and SpHNF3 (Fig. 1) . The binding of the GST-HNF3α polypeptide to the PpHNF3 and SpHNF3 sequence was compared with the binding of the purified recombinant GST-HNF4 polypeptide to the HNF4 site 2 (CpFL) sequence in the nucleocapsid promoter (Fig. 3) . The GST-HNF3α polypeptide bound to the PpHNF3 and SpHNF3 doublestranded oligonucleotides but failed to bind the CpFL doublestranded oligonucleotide. In contrast, the GST-HNF4 polypeptide bound to the CpFL double-stranded oligonucleotide but failed to bind the PpHNF3 and SpHNF3 double-stranded oligonucleotides. These observations further support the contention that there are HNF3 recognition sequences located between k231 and k240 in the major surface antigen promoter and upstream from the polymerase open reading frame between nucleotide coordinates 2164 and 2173.
Characterization of the DNA binding proteins in Huh7 nuclear extracts which interact with the HBV major surface antigen promoter and polymerase region HNF3 binding sites DNase I footprinting and gel shift analysis has demonstrated that purified recombinant GST-HNFα binds to the k231 to k240 region of the major surface antigen promoter and upstream from the polymerase open reading frame between nucleotide coordinates 2164 and 2173. To examine further if HNF3 polypeptides specifically bind to these regions,
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Regulation of HBV gene expression Regulation of HBV gene expression Fig. 1 . Fig. 3 . Gel retardation analysis of the HBV polymerase region PpHNF3 sequence element, the major surface antigen promoter SpHNF3 sequence element and the nucleocapsid promoter CpFL regulatory sequence element with purified recombinant GST-HNF3α and GST-HNF4. The 32 P-labelled, double-stranded oligonucleotides PpHNF3 (lanes 1 and 2), SpHNF3 (lanes 3 and 4) and CpFL (lanes 5 and 6) were used for this analysis with purified recombinant GST-HNF3α (lanes 1, 3 and 5) and GST-HNF4 (lanes 2, 4 and 6).
the PpHNF3 and SpHNF3 double-stranded oligonucleotides were characterized for their ability to bind proteins present in Huh7 nuclear extracts by gel shift analysis (Fig. 4) . The PpHNF3 and SpHNF3 double-stranded oligonucleotides bound protein(s) present in the Huh7 nuclear extracts demonstrating that these sequence elements are recognized by transcription factor(s) present in this cell line. To examine the specificity of the complex formed between the PpHNF3 and SpHNF3 double-stranded oligonucleotides and the protein(s) present in the Huh7 nuclear extract, several unlabelled, doublestranded oligonucleotides were used as competitors in the gel retardation analysis (Fig. 4) . Unlabelled, double-stranded oligonucleotides PpHNF3 (Fig. 1 B) , SpHNF3 (Fig. 1 A) , PS1pHNF3 (the HNF3 site in the large surface antigen promoter) and CpE (the HNF3 site 2 in the nucleocapsid promoter) efficiently competed with the $#P-labelled PpHNF3 and SpHNF3 double-stranded oligonucleotides for binding the factor(s) present in the Huh7 nuclear extract. The unlabelled major surface antigen promoter double-stranded oligonucleotides SpA (the NF1 site in the major surface antigen promoter) DADD A. K. Raney and A. McLachlan A. K. Raney and A. McLachlan Fig. 4 . Gel retardation and complex inhibition analysis of the HBV polymerase region PpHNF3 sequence element and the major surface antigen promoter SpHNF3 sequence element. The 32 P-labelled, double-stranded oligonucleotides (A) PpHNF3 (Fig.  1 B) and (B) SpHNF3 (Fig. 1 A) were analysed using an Huh7 nuclear extract. Unlabelled, double-stranded oligonucleotides were used as competitor DNAs to demonstrate the specificity of the observed complexes. PpHNF3 (lane 2), an HNF3 binding site located upstream of the polymerase open reading frame ; SpHNF3 (lane 3), the major surface antigen promoter HNF3 binding site ; PS1pHNF3 (lane 4), the large surface antigen promoter HNF3 binding site ; CpE (lane 5), the nucleocapsid promoter HNF3 binding site 2 (Johnson et al., 1995) ; SpA (lane 6), the major surface antigen promoter NF1 binding site (Shaul et al., 1986) ; SpB (lane 7), the major surface antigen promoter Sp1 binding site 1 (Raney et al., 1992) .
and SpB (the Sp1 site 1 in the major surface antigen promoter) failed to compete efficiently for the factor(s) binding the $#P-labelled PpHNF3 and SpHNF3 double-stranded oligonucleotides. These results are consistent with the PpHNF3 and SpHNF3 sequence elements specifically binding HNF3 polypeptides present in Huh7 nuclear extracts.
HNF3 can transactivate expression from a minimal promoter through the major surface antigen promoter and the polymerase region HNF3 binding sites
To examine the functional properties of the major surface antigen promoter and polymerase region HNF3 binding sites, they were examined for their capacity to mediate transcriptional transactivation by HNF3 in the context of a TATA-box element. The SpHNF3 and PpHNF3 double-stranded oligonucleotide synthetic promoter elements were cloned upstream of a TATA-box element and the luciferase open reading frame (LUC) and were tested for their transcriptional activities in HepG2.1 cells in the presence or absence of the HNF3β expression vector (Fig. 5) . In the absence of the HNF3 expression vector, the constructs containing the major surface antigen promoter HNF3 site [construct SpHNF3(5)LUC and SpHNF3(7)LUC] had very little transcriptional activity. When the HNF3 polypeptide was exogenously expressed, the synthetic constructs containing the SpHNF3 sites were transcriptionally activated to a level similar to that observed for the HNF3 binding site in the HBV large surface antigen promoter [constructs PS1pHNF3(2)LUC and PS1pHNF-3(3)LUC] , the nucleocapsid promoter [construct CpE(3)LUC] (Johnson et al., 1995) was not activated by the exogenous expression of the HNF3 transcription factor. Therefore, the SpHNF3 double-stranded oligonucleotide containing the major surface antigen promoter HNF3 binding site appears to be a functional site which can DADE Regulation of HBV gene expression Regulation of HBV gene expression Fig. 5 . Functional analysis of the HBV major surface antigen promoter and polymerase region HNF3 binding sites. The constructs examined contain the SpHNF3 (the major surface antigen promoter HNF3 site), PS1pHNF3 (the large surface antigen promoter HNF3 site), CpE (the nucleocapsid promoter HNF3 site 2), PpHNF3 (the HNF3 site located upstream of the polymerase open reading frame), CpB (the nucleocapsid promoter Sp1 site 2) and PS1pHNF1 (the large surface antigen promoter HNF1 site) double-stranded oligonucleotide cloned into the minimal promoter construct pHBVTATALUC (see insert). The number of copies of the oligonucleotide in the construct is shown in parentheses in the construct name. The relative activities of the constructs in the presence of the expression vectors, pCMV (kHNF3) or pCMVHNF3β (jHNF3), were examined in HepG2.1 cells. The transcriptional activities are reported relative to the SpHNF3(5)LUC plasmid in the presence of the HNF3β expression vector, which is designated as having a relative activity of 1n0. The standard deviation of the mean is indicated by an error bar. The internal control used to correct for transfection efficiencies was pCMVβ. mediate specific transcriptional transactivation by HNF3β in the context of a TATA-box sequence to a level similar to that previously reported for the HNF3 binding sites in the large surface antigen and nucleocapsid promoters Johnson et al., 1995) . This observation is in apparent contrast to the observation that HNF3β only increases transcription from the major surface antigen promoter approximately 2-fold under conditions where transcription from the large surface antigen promoter is increased approximately 80-fold . Similarly, the PpHNF3 doublestranded oligonucleotide containing the polymerase region HNF3 binding site appears to be a functional site which can mediate specific transcriptional transactivation by HNF3β in the context of a TATA-box sequence to a level similar to that observed for the other HBV HNF3 binding sites. These results appear to demonstrate a limitation of the analysis of the viral promoters in cell culture by transient transfection as it failed to identify all the functional HNF3 binding sites in the HBV genome. A role for these additional HNF3 sites in determining the level of transcription from the HBV promoters in vivo may contribute to the differences in tissue specificity observed between viral transcription in transgenic mice or infected individuals and the patterns of transcription observed in cell culture.
Discussion
Studies aimed at understanding the mechanisms governing the coordinate and liver-specific regulation of HBV transcription have primarily been performed by transient transfection analysis using a variety of nonliver-and liver-derived cell lines. This approach has been successful in demonstrating the involvement of transcription factors such as NF1, Sp1, C\EBP, HNF3, HNF4, RXRα and PPARα in regulating the level of transcription from multiple HBV promoters which may explain, in part, both the coordinate regulation of HBV transcription and the preferential expression of HBV RNAs in liver-derived cell lines. However, these studies have failed to DADF
